Queens-Long Island Oncology & Hematology Pc is categorized under Hematologists in Flushing, NY and active since 2007.
Queens-Long Island Oncology & Hematology Pc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Richard L Xu at the company’s single location by writing to 3907 Prince St, Flushing, New York NY 11354 or by phoning (718) 888-7801. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Queens-Long Island Oncology & Hematology Pc |
Contact Person: | Richard L Xu |
Address: | 3907 Prince St, Flushing, New York 11354 |
Phone Number: | (718) 888-7801 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Hematologists |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Queens-Long Island Oncology & Hematology Pc was started in 2007 to provide professional Hematologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Richard L Xu for inquiries that concern Queens-Long Island Oncology & Hematology Pc by calling the company number (718) 888-7801, as your correspondence is most welcome. Additionally, the physical location of the single location of Queens-Long Island Oncology & Hematology Pc can be found at the coordinates 40.75958,-73.832092 as well as the street address 3907 Prince St in Flushing, New York 11354.
For its online presence, you may visit Queens-Long Island Oncology & Hematology Pc’s website at and engage with its social media outlets through on Twitter and on Facebook.